BBIO · earnings call history
BridgeBio Pharma, Inc. Q2 FY26 — Attruby Growth and Pipeline Advancement
Read the briefBridgeBio Pharma Q1 FY26 — Strong Attruby Growth and Share Repurchase Program
Read the briefBridgeBio Q4 FY25 — Transformative Inflection Point with Multiple Late-Stage Readouts and Strong Attruby Growth
Read the briefBrowse all US companies on the earnings-call register.